The bile acid receptor TGR5 and cholestasis

During liver injury and cholestasis, the mechanisms allowing the organ to protect itself with the aim of maintaining biliary homeostasis are not completely understood. Central to their biological roles, bile acids (BAs) and their receptors constitute a signaling network with multiple molecular and cellular impacts on both liver repair and protection from BA overload. BA signal through nuclear [mainly farnesoid X receptor (FXR)] and membrane [mainly G protein-coupled BA receptor 1 (GPBAR-1), aka Takeda G protein-coupled receptor 5 (TGR5)] receptors, in which activation elicits a wide array of biological responses. So far, most of the studies have been focused on FXR signaling as hepato-protective, TGR5 being less explored to this regard. While the liver faces massive and potentially harmful BA overload during cholestasis, it is crucial to understand that BAs induce also protective responses contributing not only to reduce the inflammatory burden, but also to spare liver cells and their repair capacities. Based on the available literature, the TGR5 BA receptor protects the liver in the cholestatic context and counteracts BA overload with the aim of restoring biliary homeostasis mainly through the control of inflammatory processes, biliary epithelial barrier permeability, and BA pool composition. Mouse experimental models of cholestasis reveal that the lack of TGR5 was associated with exacerbated inflammation and necrosis, leaky biliary epithelium, and excessive BA pool hydrophobicity, resulting in biliary cell and parenchymal insult, and compromising optimal restoration of biliary homeostasis and liver repair. There are thus widely opened translational perspectives with the aim of targeting TGR5-related signaling or biological responses to trigger protection of the cholestatic liver.

[1]  I. Leclercq,et al.  Enterohepatic Takeda G-Protein Coupled Receptor 5 Agonism in Metabolic Dysfunction-Associated Fatty Liver Disease and Related Glucose Dysmetabolism , 2022, Nutrients.

[2]  R. Fiorotto,et al.  Bile acids and their receptors: modulators and therapeutic targets in liver inflammation , 2022, Seminars in Immunopathology.

[3]  C. Sempoux,et al.  Bile acids contribute to the development of non-alcoholic steatohepatitis in mice , 2021, JHEP reports : innovation in hepatology.

[4]  J. Rao,et al.  Corrigendum to: Deficiency of TGR5 exacerbates immune-mediated cholestatic hepatic injury by stabilizing the β-catenin destruction complex , 2021, International Immunology.

[5]  Haojun Yang,et al.  TGR5 protects against cholestatic liver disease via suppressing the NF-κB pathway and activating the Nrf2/HO-1 pathway , 2021, Annals of translational medicine.

[6]  T. Luedde,et al.  Downregulation of TGR5 (GPBAR1) in biliary epithelial cells contributes to the pathogenesis of sclerosing cholangitis. , 2021, Journal of hepatology.

[7]  F. Tacke,et al.  Circulating Bile Acids in Liver Failure Activate TGR5 and Induce Monocyte Dysfunction , 2021, Cellular and molecular gastroenterology and hepatology.

[8]  Shan Hu,et al.  Activation of TGR5 restores AQP2 expression via HIF pathway in renal ischemia/reperfusion injury. , 2021, American journal of physiology. Renal physiology.

[9]  R. Boisgard,et al.  TGR5 controls bile acid composition and gallbladder function to protect the liver from bile acid overload , 2020, JHEP reports : innovation in hepatology.

[10]  J. C. Wolters,et al.  Cholangiopathy and Biliary Fibrosis in Cyp2c70-Deficient Mice Are Fully Reversed by Ursodeoxycholic Acid , 2020, Cellular and molecular gastroenterology and hepatology.

[11]  M. Itoh,et al.  The zonula occludens protein family regulates the hepatic barrier system in the murine liver. , 2020, Biochimica et biophysica acta. Molecular basis of disease.

[12]  B. Cummings,et al.  TGR5 Signaling in Hepatic Metabolic Health , 2020, Nutrients.

[13]  John H. Zhang,et al.  Correction to: Activation of TGR5 protects blood brain barrier via the BRCA1/Sirt1 pathway after middle cerebral artery occlusion in rats , 2020, Journal of Biomedical Sciences.

[14]  J. Chiang,et al.  Bile acid-based therapies for non-alcoholic steatohepatitis and alcoholic liver disease. , 2020, Hepatobiliary surgery and nutrition.

[15]  T. Tordjmann,et al.  Hepatoprotective impact of the bile acid receptor TGR5 , 2020, Liver international : official journal of the International Association for the Study of the Liver.

[16]  Y. Bao,et al.  Hyocholic acid species improve glucose homeostasis through a distinct TGR5 and FXR signaling mechanism. , 2020, Cell metabolism.

[17]  Lingpeng Zhu,et al.  TGR5 receptor activation attenuates diabetic retinopathy through suppression of RhoA/ROCK signaling , 2020, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  H. Nakauchi,et al.  Vasoactive Intestinal Peptide Derived From Liver Mesenchymal Cells Mediates Tight Junction Assembly in Mouse Intrahepatic Bile Ducts , 2019, Hepatology Communications.

[19]  Yan Yang,et al.  Gentiopicroside activates the bile acid receptor Gpbar1 (TGR5) to repress NF-kappaB pathway and ameliorate diabetic nephropathy (original article). , 2019, Pharmacological research.

[20]  Satoru Takahashi,et al.  Regulation of bile acid metabolism in mouse models with hydrophobic bile acid composition[S] , 2019, Journal of Lipid Research.

[21]  A. Carino,et al.  Ursodeoxycholic acid is a GPBAR1 agonist and resets liver/intestinal FXR signaling in a model of diet-induced dysbiosis and NASH. , 2019, Biochimica et biophysica acta. Molecular and cell biology of lipids.

[22]  J. C. Wolters,et al.  A human-like bile acid pool induced by deletion of hepatic Cyp2c70 modulates effects of FXR activation in mice[S] , 2019, Journal of Lipid Research.

[23]  H. Jaeschke,et al.  INFLAMMATION AND CELL DEATH DURING CHOLESTASIS: THE EVOLVING ROLE OF BILE ACIDS. , 2019, Gene expression.

[24]  Yi-horng Lee,et al.  FXR deficiency alters bile acid pool composition and exacerbates chronic alcohol induced liver injury. , 2019, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[25]  S. V. D. van de Graaf,et al.  Developments in bile salt based therapies: A critical overview , 2019, Biochemical pharmacology.

[26]  Baolei Jia Commentary: Gut microbiome–mediated bile acid metabolism regulates liver cancer via NKT cells , 2019, Front. Immunol..

[27]  T. Tordjmann,et al.  TGR5-dependent hepatoprotection through the regulation of biliary epithelium barrier function , 2019, Gut.

[28]  M. Zerial,et al.  Claudin-3 regulates bile canalicular paracellular barrier and cholesterol gallstone core formation in mice. , 2018, Journal of hepatology.

[29]  C. Borchers,et al.  Hydrophilic bile acids prevent liver damage caused by lack of biliary phospholipid in Mdr2−/− mice[S] , 2018, Journal of Lipid Research.

[30]  D. Häussinger,et al.  Role of TGR5 (GPBAR1) in Liver Disease , 2018, Seminars in Liver Disease.

[31]  K. Kodys,et al.  FXR and TGR5 Agonists Ameliorate Liver Injury, Steatosis, and Inflammation After Binge or Prolonged Alcohol Feeding in Mice , 2018, Hepatology communications.

[32]  T. Kwon,et al.  Bile Acid G Protein-Coupled Membrane Receptor TGR5 Modulates Aquaporin 2-Mediated Water Homeostasis. , 2018, Journal of the American Society of Nephrology : JASN.

[33]  Simon C Watkins,et al.  Dysregulated Bile Transporters and Impaired Tight Junctions During Chronic Liver Injury in Mice. , 2018, Gastroenterology.

[34]  F. Gonzalez,et al.  Intestine farnesoid X receptor agonist and the gut microbiota activate G‐protein bile acid receptor‐1 signaling to improve metabolism , 2018, Hepatology.

[35]  Simon C Watkins,et al.  Dual catenin loss in murine liver causes tight junctional deregulation and progressive intrahepatic cholestasis , 2018, Hepatology.

[36]  Junichi Ikenouchi,et al.  Regulation of the epithelial barrier by post-translational modifications of tight junction membrane proteins. , 2018, Journal of biochemistry.

[37]  M. Hayden,et al.  Therapeutic modulation of the bile acid pool by Cyp8b1 knockdown protects against nonalcoholic fatty liver disease in mice , 2018, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[38]  S. Glaser,et al.  Mechanisms of cholangiocyte responses to injury. , 2017, Biochimica et biophysica acta. Molecular basis of disease.

[39]  T. Tordjmann,et al.  Bile acids and their receptors during liver regeneration: "Dangerous protectors". , 2017, Molecular aspects of medicine.

[40]  J. Boyer,et al.  Mechanisms of bile acid mediated inflammation in the liver. , 2017, Molecular aspects of medicine.

[41]  D. Francisci,et al.  The Bile Acid Receptor GPBAR1 Regulates the M1/M2 Phenotype of Intestinal Macrophages and Activation of GPBAR1 Rescues Mice from Murine Colitis , 2017, The Journal of Immunology.

[42]  Hui Qi,et al.  The G-protein-coupled bile acid receptor Gpbar1 (TGR5) protects against renal inflammation and renal cancer cell proliferation and migration through antagonizing NF-κB and STAT3 signaling pathways. , 2017, Oncotarget.

[43]  F. Gonzalez,et al.  Farnesoid X Receptor Regulation of the NLRP3 Inflammasome Underlies Cholestasis-Associated Sepsis. , 2017, Cell metabolism.

[44]  D. Jain,et al.  Bile acids initiate cholestatic liver injury by triggering a hepatocyte-specific inflammatory response. , 2017, JCI insight.

[45]  J. Chiang,et al.  G‐protein‐coupled bile acid receptor plays a key role in bile acid metabolism and fasting‐induced hepatic steatosis in mice , 2017, Hepatology.

[46]  H. Hsu,et al.  Prognostic roles of tetrahydroxy bile acids in infantile intrahepatic cholestasis[S] , 2017, Journal of Lipid Research.

[47]  J. Hampe,et al.  The ascending pathophysiology of cholestatic liver disease , 2017, Hepatology.

[48]  P. Chiba,et al.  Metabolic preconditioning protects BSEP/ABCB11-/- mice against cholestatic liver injury. , 2017, Journal of hepatology.

[49]  Yingwei Chen,et al.  Chenodeoxycholic acid activates NLRP3 inflammasome and contributes to cholestatic liver fibrosis , 2016, Oncotarget.

[50]  C. Brocker,et al.  Cyp2c70 is responsible for the species difference in bile acid metabolism between mice and humans[S] , 2016, Journal of Lipid Research.

[51]  Dustin E. Schones,et al.  Vertical sleeve gastrectomy activates GPBAR‐1/TGR5 to sustain weight loss, improve fatty liver, and remit insulin resistance in mice , 2016, Hepatology.

[52]  D. Xia,et al.  Bile Acids Control Inflammation and Metabolic Disorder through Inhibition of NLRP3 Inflammasome. , 2016, Immunity.

[53]  Yingjie Yu,et al.  The G-Protein-Coupled Bile Acid Receptor Gpbar1 (TGR5) Inhibits Gastric Inflammation Through Antagonizing NF-κB Signaling Pathway , 2015, Front. Pharmacol..

[54]  R. Ley,et al.  TGR5 contributes to glucoregulatory improvements after vertical sleeve gastrectomy in mice , 2015, Gut.

[55]  D. Häussinger,et al.  TGR5 is essential for bile acid-dependent cholangiocyte proliferation in vivo and in vitro , 2015, Gut.

[56]  T. Tordjmann,et al.  The Bile Acid Receptor TGR5 and Liver Regeneration , 2015, Digestive Diseases.

[57]  Richard J. Thompson,et al.  Mutations in TJP2, encoding zona occludens 2, and liver disease , 2015, Tissue barriers.

[58]  T. Tordjmann,et al.  Bile acids and FGF receptors: orchestrators of optimal liver regeneration , 2015, Gut.

[59]  N. Schmiedeberg,et al.  G-protein-coupled bile acid receptor 1 (GPBAR1, TGR5) agonists reduce the production of proinflammatory cytokines and stabilize the alternative macrophage phenotype. , 2014, Journal of medicinal chemistry.

[60]  C. V. Van Itallie,et al.  Architecture of tight junctions and principles of molecular composition. , 2014, Seminars in cell & developmental biology.

[61]  K. Schoonjans,et al.  TGR5 reduces macrophage migration through mTOR-induced C/EBPβ differential translation. , 2014, The Journal of clinical investigation.

[62]  S. Werner,et al.  Control of hepatocyte proliferation and survival by Fgf receptors is essential for liver regeneration in mice , 2014, Gut.

[63]  J. Boyer The hepatobiliary paracellular pathway: a paradigm revisited. , 2014, Gastroenterology.

[64]  H. Eguchi,et al.  Claudin 2 deficiency reduces bile flow and increases susceptibility to cholesterol gallstone disease in mice. , 2014, Gastroenterology.

[65]  B. Harvey,et al.  Bile acids stimulate chloride secretion through CFTR and calcium-activated Cl- channels in Calu-3 airway epithelial cells. , 2014, American journal of physiology. Lung cellular and molecular physiology.

[66]  L. Adorini,et al.  Semisynthetic Bile Acid FXR and TGR5 Agonists: Physicochemical Properties, Pharmacokinetics, and Metabolism in the Rat , 2014, The Journal of Pharmacology and Experimental Therapeutics.

[67]  W. Naugler Bile Acid Flux Is Necessary for Normal Liver Regeneration , 2014, PLoS ONE.

[68]  D. Herranz,et al.  SIRT1 controls liver regeneration by regulating bile acid metabolism through farnesoid X receptor and mammalian target of rapamycin signaling , 2014, Hepatology.

[69]  Xi Chen,et al.  Novel mechanistic insights into ectodomain shedding of EGFR Ligands Amphiregulin and TGF-α: impact on gastrointestinal cancers driven by secondary bile acids. , 2014, Cancer research.

[70]  T. Murata,et al.  Stimulation of G Protein–Coupled Bile Acid Receptor Enhances Vascular Endothelial Barrier Function via Activation of Protein Kinase A and Rac1 , 2014, The Journal of Pharmacology and Experimental Therapeutics.

[71]  V. Ling,et al.  Hepatic bile acid metabolism and expression of cytochrome P450 and related enzymes are altered in Bsep−/− mice , 2014, Molecular and Cellular Biochemistry.

[72]  B. Bhushan,et al.  GASTROINTESTINAL , HEPATOBILIARY , AND PANCREATIC PATHOLOGY Role of Bile Acids in Liver Injury and Regeneration following Acetaminophen Overdose , 2013 .

[73]  T. Tordjmann,et al.  The receptor TGR5 protects the liver from bile acid overload during liver regeneration in mice , 2013, Hepatology.

[74]  Yu-Chung Wu,et al.  Bile acids increase alveolar epithelial permeability via mitogen‐activated protein kinase, cytosolic phospholipase A2, cyclooxygenase‐2, prostaglandin E2 and junctional proteins , 2013, Respirology.

[75]  N. Lambert,et al.  The Bile Acid Receptor TGR5 Does Not Interact with β-Arrestins or Traffic to Endosomes but Transmits Sustained Signals from Plasma Membrane Rafts* , 2013, The Journal of Biological Chemistry.

[76]  N. LaRusso,et al.  Ciliary subcellular localization of TGR5 determines the cholangiocyte functional response to bile acid signaling. , 2013, American journal of physiology. Gastrointestinal and liver physiology.

[77]  T. Berg,et al.  Increased T-helper 2 cytokines in bile from patients with IgG4-related cholangitis disrupt the tight junction-associated biliary epithelial cell barrier. , 2013, Gastroenterology.

[78]  R. Tavares,et al.  Expression of bile acid receptor TGR5 in gastric adenocarcinoma. , 2013, American journal of physiology. Gastrointestinal and liver physiology.

[79]  S. Morini,et al.  Identification of fibroblast growth factor 15 as a novel mediator of liver regeneration and its application in the prevention of post-resection liver failure in mice , 2013, Gut.

[80]  M. Rietkerk,et al.  Bile salts predict liver regeneration in rabbit model of portal vein embolization. , 2012, The Journal of surgical research.

[81]  R. Chamuleau,et al.  Can Plasma Bile Salt, Triglycerides, and apoA-V Levels Predict Liver Regeneration? , 2012, World Journal of Surgery.

[82]  P. Dawson,et al.  Defects in gallbladder emptying and bile Acid homeostasis in mice with cystic fibrosis transmembrane conductance regulator deficiencies. , 2012, Gastroenterology.

[83]  D. Cassio,et al.  Claudin‐1 involved in neonatal ichthyosis sclerosing cholangitis syndrome regulates hepatic paracellular permeability , 2012, Hepatology.

[84]  A. Suzuki,et al.  aPKC phosphorylates JAM-A at Ser285 to promote cell contact maturation and tight junction formation , 2012, The Journal of cell biology.

[85]  M. Trauner,et al.  Selective activation of nuclear bile acid receptor FXR in the intestine protects mice against cholestasis. , 2012, Gastroenterology.

[86]  S. Catalano,et al.  Chenodeoxycholic acid through a TGR5-dependent CREB signaling activation enhances Cyclin D1 expression and promotes human endometrial cancer cell proliferation , 2012, Cell cycle.

[87]  C. Paulusma,et al.  A biliary HCO3− umbrella constitutes a protective mechanism against bile acid‐induced injury in human cholangiocytes , 2012, Hepatology.

[88]  J. Auwerx,et al.  TGR5 activation inhibits atherosclerosis by reducing macrophage inflammation and lipid loading. , 2011, Cell metabolism.

[89]  G. Bifulco,et al.  The Bile Acid Receptor GPBAR-1 (TGR5) Modulates Integrity of Intestinal Barrier and Immune Response to Experimental Colitis , 2011, PloS one.

[90]  B. M. Forman,et al.  The G‐Protein‐coupled bile acid receptor, Gpbar1 (TGR5), negatively regulates hepatic inflammatory response through antagonizing nuclear factor kappa light‐chain enhancer of activated B cells (NF‐κB) in mice , 2011, Hepatology.

[91]  A. Baghdasaryan,et al.  Dual farnesoid X receptor/TGR5 agonist INT‐767 reduces liver injury in the Mdr2−/− (Abcb4−/−) mouse cholangiopathy model by promoting biliary HCO  3− output , 2011, Hepatology.

[92]  J. Auwerx,et al.  The bile acid membrane receptor TGR5 as an emerging target in metabolism and inflammation. , 2011, Journal of hepatology.

[93]  S. Kliewer,et al.  The G protein-coupled bile acid receptor, TGR5, stimulates gallbladder filling. , 2011, Molecular endocrinology.

[94]  D. Samuel,et al.  Immediate neuroendocrine signaling after partial hepatectomy through acute portal hyperpressure and cholestasis. , 2011, Journal of hepatology.

[95]  K. Zilles,et al.  The bile acid receptor TGR5 (Gpbar‐1) acts as a neurosteroid receptor in brain , 2010, Glia.

[96]  D. Häussinger,et al.  The membrane-bound bile acid receptor TGR5 (Gpbar-1) is localized in the primary cilium of cholangiocytes , 2010, Biological chemistry.

[97]  U. Beuers,et al.  Bile salts and cholestasis. , 2010, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

[98]  H. Pan,et al.  FXR regulates liver repair after CCl4-induced toxic injury. , 2010, Molecular endocrinology.

[99]  Jie Hong,et al.  Role of a novel bile acid receptor TGR5 in the development of oesophageal adenocarcinoma , 2009, Gut.

[100]  J. Auwerx,et al.  TGR5-mediated bile acid sensing controls glucose homeostasis. , 2009, Cell metabolism.

[101]  D. Häussinger,et al.  The membrane‐bound bile acid receptor TGR5 is localized in the epithelium of human gallbladders , 2009, Hepatology.

[102]  C. Klaassen,et al.  Role of hepatic transporters in prevention of bile acid toxicity after partial hepatectomy in mice. , 2009, American journal of physiology. Gastrointestinal and liver physiology.

[103]  C. V. Van Itallie,et al.  Physiology and function of the tight junction. , 2009, Cold Spring Harbor perspectives in biology.

[104]  Johan Auwerx,et al.  Targeting bile-acid signalling for metabolic diseases , 2008, Nature Reviews Drug Discovery.

[105]  D. Häussinger,et al.  Expression and function of the bile acid receptor TGR5 in Kupffer cells. , 2008, Biochemical and biophysical research communications.

[106]  Stacy A. Johnson,et al.  Loss of orphan receptor small heterodimer partner sensitizes mice to liver injury from obstructive cholestasis , 2008, Hepatology.

[107]  C. Apicella,et al.  Bile acids modulate tight junction structure and barrier function of Caco-2 monolayers via EGFR activation. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[108]  J. Auwerx,et al.  Novel potent and selective bile acid derivatives as TGR5 agonists: biological screening, structure-activity relationships, and molecular modeling studies. , 2008, Journal of medicinal chemistry.

[109]  N. LaRusso,et al.  Cholangiocyte cilia express TRPV4 and detect changes in luminal tonicity inducing bicarbonate secretion , 2007, Proceedings of the National Academy of Sciences.

[110]  Hiroshi Yasuda,et al.  Involvement of membrane-type bile acid receptor M-BAR/TGR5 in bile acid-induced activation of epidermal growth factor receptor and mitogen-activated protein kinases in gastric carcinoma cells. , 2007, Biochemical and biophysical research communications.

[111]  M. Trauner,et al.  Principles of hepatic organic anion transporter regulation during cholestasis, inflammation and liver regeneration. , 2007, Biochimica et biophysica acta.

[112]  D. Häussinger,et al.  The G‐protein coupled bile salt receptor TGR5 is expressed in liver sinusoidal endothelial cells , 2007, Hepatology.

[113]  H. Miyoshi,et al.  Targeted disruption of G protein-coupled bile acid receptor 1 (Gpbar1/M-Bar) in mice. , 2006, The Journal of endocrinology.

[114]  H. Davis,et al.  Targeted deletion of Gpbar1 protects mice from cholesterol gallstone formation. , 2006, The Biochemical journal.

[115]  D. Moore,et al.  Nuclear Receptor-Dependent Bile Acid Signaling Is Required for Normal Liver Regeneration , 2006, Science.

[116]  K. Zatloukal,et al.  Lithocholic acid feeding induces segmental bile duct obstruction and destructive cholangitis in mice. , 2006, The American journal of pathology.

[117]  A. Smahi,et al.  Claudin-1 gene mutations in neonatal sclerosing cholangitis associated with ichthyosis: a tight junction disease. , 2004, Gastroenterology.

[118]  R. Taub Liver regeneration: from myth to mechanism , 2004, Nature Reviews Molecular Cell Biology.

[119]  H. Tilg,et al.  Regurgitation of bile acids from leaky bile ducts causes sclerosing cholangitis in Mdr2 (Abcb4) knockout mice. , 2004, Gastroenterology.

[120]  D. Häussinger,et al.  Bile salt-induced hepatocyte apoptosis involves epidermal growth factor receptor-dependent CD95 tyrosine phosphorylation. , 2003, Gastroenterology.

[121]  Masataka Harada,et al.  A G Protein-coupled Receptor Responsive to Bile Acids* , 2003, The Journal of Biological Chemistry.

[122]  Takao Nakamura,et al.  Identification of membrane-type receptor for bile acids (M-BAR). , 2002, Biochemical and biophysical research communications.

[123]  F. Di Virgilio,et al.  Proinflammatory cytokines inhibit secretion in rat bile duct epithelium. , 2001, Gastroenterology.

[124]  T. Kawaguchi,et al.  Alterations in tight junctions differ between primary biliary cirrhosis and primary sclerosing cholangitis , 2001, Hepatology.

[125]  R. Sokol,et al.  Bile acid‐induced rat hepatocyte apoptosis is inhibited by antioxidants and blockers of the mitochondrial permeability transition , 2001, Hepatology.

[126]  F. Carubbi,et al.  Review article: effect of bile salt pool composition on hepatic and biliary functions , 2000, Alimentary pharmacology & therapeutics.

[127]  G. Gores,et al.  Hepatocyte apoptosis after bile duct ligation in the mouse involves Fas. , 1999, Gastroenterology.

[128]  B. Stieger,et al.  Structure-function correlation of tight junctional impairment after intrahepatic and extrahepatic cholestasis in rat liver. , 1996, Gastroenterology.